These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12503092)
1. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. Tal Y; Souan L; Cohen IR; Meiner Z; Taraboulos A; Mor F J Neurosci Res; 2003 Jan; 71(2):286-90. PubMed ID: 12503092 [TBL] [Abstract][Full Text] [Related]
2. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329 [TBL] [Abstract][Full Text] [Related]
3. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030 [TBL] [Abstract][Full Text] [Related]
4. Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice. Sacquin A; Chaigneau T; Defaweux V; Adam M; Schneider B; Bruley Rosset M; Eloit M Brain Behav Immun; 2012 Aug; 26(6):919-30. PubMed ID: 22522067 [TBL] [Abstract][Full Text] [Related]
5. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases. Zuber C; Knackmuss S; Rey C; Reusch U; Röttgen P; Fröhlich T; Arnold GJ; Pace C; Mitteregger G; Kretzschmar HA; Little M; Weiss S Mol Immunol; 2008 Jan; 45(1):144-51. PubMed ID: 17576014 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436 [TBL] [Abstract][Full Text] [Related]
7. Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material. Murphy RG; Scanga JA; Powers BE; Pilon JL; Vercauteren KC; Nash PB; Smith GC; Belk KE J Anim Sci; 2009 May; 87(5):1787-93. PubMed ID: 19098230 [TBL] [Abstract][Full Text] [Related]
8. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796 [TBL] [Abstract][Full Text] [Related]
10. Resistance of cell lines to prion toxicity aided by phospho-ERK expression. Uppington KM; Brown DR J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369 [TBL] [Abstract][Full Text] [Related]
11. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. Spinner DS; Kascsak RB; Lafauci G; Meeker HC; Ye X; Flory MJ; Kim JI; Schuller-Levis GB; Levis WR; Wisniewski T; Carp RI; Kascsak RJ J Leukoc Biol; 2007 Jun; 81(6):1374-85. PubMed ID: 17379700 [TBL] [Abstract][Full Text] [Related]
12. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194 [TBL] [Abstract][Full Text] [Related]
13. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system. Vollmar P; Kullmann JS; Thilo B; Claussen MC; Rothhammer V; Jacobi H; Sellner J; Nessler S; Korn T; Hemmer B J Immunol; 2010 Nov; 185(10):6338-47. PubMed ID: 20943998 [TBL] [Abstract][Full Text] [Related]
14. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice. Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein. Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207 [TBL] [Abstract][Full Text] [Related]
16. PrPSc level and incubation time in a transgenic mouse model expressing Borna disease virus phosphoprotein after intracerebral prion infection. Sakudo A; Onodera T; Ikuta K Neurosci Lett; 2008 Jan; 431(1):81-5. PubMed ID: 18155836 [TBL] [Abstract][Full Text] [Related]
17. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K]. Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162 [TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Ishibashi D; Yamanaka H; Yamaguchi N; Yoshikawa D; Nakamura R; Okimura N; Yamaguchi Y; Shigematsu K; Katamine S; Sakaguchi S Vaccine; 2007 Jan; 25(6):985-92. PubMed ID: 17055125 [TBL] [Abstract][Full Text] [Related]
19. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin treatment prolongs the survival of scrapie-infected mice. Kempster S; Bate C; Williams A Neuroreport; 2007 Mar; 18(5):479-82. PubMed ID: 17496807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]